Home
Live Updates
Alvotech And STADA Obtain Approval In Europe For Ustekinumab Biosimilar, UZPRUVO : comparemela.com
Alvotech And STADA Obtain Approval In Europe For Ustekinumab Biosimilar, UZPRUVO
On January 10, Alvotech announced that the European Commission issued a marketing authorization to its European commercialization partner, STADA, for UZPRUVO , a biosimilar referencing STELARA . The...
Related Keywords
Canada ,
Liechtenstein ,
Japan ,
Norway ,
Iceland ,
,
European Commission ,
Pharma Group ,
European Economic Area ,
Supplementary Protection Certificate ,
Big Molecule Watch ,
Markets ,
comparemela.com © 2020. All Rights Reserved.